Evidence map›Paper›PMID 35106045›Full record

ArticleEthnicity & disease

Advancing Inclusive Research: Establishing Collaborative Strategies to Improve Diversity in Clinical Trials.

Owen Garrick, Ruben Mesa, Andrea Ferris, Edward S Kim, Edith Mitchell, Otis W Brawley, John Carpten, Keith D Carter, Joseph Coney, Robert Winn and 12 more

Abstract read
In one paragraph

Article in Ethnicity & disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Trial
  2. Faith, Culture, and Cancer: A Qualitative Study Exploring Muslim Women's Perspectives on Clinical Trials in the United Kingdom.Health expectations : an international journal of public participation in health care and health policy · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Owen GarrickCVS Health, San Francisco, CA.
Ruben MesaMays Cancer Center at UT Health San Antonio, San Antonio, TX.
Andrea FerrisLUNGevity Foundation, Chicago, IL.
Edward S KimCity of Hope Orange County, Newport Beach, CA.
Edith MitchellSidney Kimmel Cancer Center - Jefferson Health, Philadelphia, PA.
Otis W BrawleyThe Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD.
John CarptenDepartment of Translational Genomics, Keck School of Medicine of University of Southern California, Los Angeles, CA.
Keith D CarterDepartment of Ophthalmology, University of Iowa, Iowa City, IA.
Joseph ConeyRetina Associates of Cleveland, Cleveland, OH.
Robert WinnMassey Cancer Center, Virginia Commonwealth University, Richmond, VA.
Stephanie MonroeUsAgainstAlzheimer's African American Network, Washington, DC.
Fabian SandovalEmerson Clinical Research Institute, Washington, DC.
Edith PerezDivision of Hematology and Oncology, Mayo Clinic, Jacksonville, FL.
Mitzi WilliamsJoi Life Wellness Group, Atlanta, GA.
Evan GroveBravo Group, Harrisburg, PA.
Quita HighsmithGenentech Inc., South San Francisco, CA.
Nicole RichieGenentech Inc., South San Francisco, CA.
Susan M BegelmanGenentech Inc., South San Francisco, CA.
Asha S CollinsGenentech Inc., South San Francisco, CA.
Jamie FreedmanGenentech Inc., South San Francisco, CA.
Melissa S GonzalesGenentech Inc., South San Francisco, CA.
Gerren WilsonGenentech Inc., South San Francisco, CA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Well-characterized disparities in clinical research have disproportionately affected patients of color, particularly in underserved communities. To tackle these barriers, Genentech formed the External Council for Advancing Inclusive Research, a 14-person committee dedicated to developing strategies to increase clinical research participation. To help improve the recruitment and retention of patients of color, this article chronicles our efforts to tangibly address the clinical research barriers at the system, study, and patient levels over the last four years. These efforts are one of the initial steps to fully realize the promise of personalized health care and provide increased patient benefit at less cost to society. Instead of simply acknowledging the problem, here we illuminate the collaborative and multilevel strategies that have been effective in delivering meaningful progress for patients.

Indexed as

Clinical Trial DesignCOVID-19Health Care DisparitiesMinority HealthPersonalized Health Care

Identifiers

PMID35106045
PMCPMC8785867

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.